CENTRAL RAILWAY has floated a tender for Inj Adalimumab 40 Mg 0.8 Ml Pfs - Exemptia 40 Mg. The project location is Mumbai, Maharashtra, India. The reference number is CRM181970005NGP-A and it is closing on 27 Apr 2018.
Suppliers can request Register free of cost to get the complete Tender details and download the document.